SC Filed 2023-05-23 Event — SEC 0000921895-23-001333 →

Apeiron Investment Group Ltd. → Sensei Biotherapeutics, Inc. SNSE

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

8 filings by this filer

7 other filings in the data moat

Short Interest · settle 2026-06-15

DTC 9.11

615,413 shares short · -22.9% vs prior

Other 13D/G Filings on Sensei Biotherapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-06-23	SCHEDULE 13G	SUVRETTA CAPITAL MANAGEMENT, LLC	—	—	view →
2026-06-23	SCHEDULE 13G	S2G Investments, LLC	—	—	view →
2022-11-21	SC	Apeiron Investment Group Ltd.	—	—	view →

Other Filings by Apeiron Investment Group Ltd.

Filed	Form	Issuer	Stake	Shares
2026-07-24	SCHEDULE 13D/A	Enhanced Group Inc.	26.60%	35,945,876	view →
2026-07-17	SCHEDULE 13D/A	AtaiBeckley Inc.	15.40%	55,770,948	view →
2026-06-16	SCHEDULE 13D/A	Enhanced Group Inc. ENHA	24.40%	29,904,746	view →
2026-05-14	SCHEDULE 13D	Enhanced Group Inc. ENHA	24.40%	29,904,746	view →
2025-01-28	SCHEDULE	Neuphoria Therapeutics Inc. NEUP	4.50%	72,618	view →
2024-10-07	SC	BIONOMICS LIMITED/FI NEUP	—	—	view →
2022-11-21	SC	Sensei Biotherapeutics, Inc. SNSE	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →